Cargando…
HUCBC Treatment Improves Cognitive Outcome in Rats With Vascular Dementia
Background and purpose: Vascular dementia (VaD) is the second common cause of dementia after Alzheimer’s disease in older people. Yet, there are no FDA approved drugs specifically for VaD. In this study, we have investigated the therapeutic effects of human umbilical cord blood cells (HUCBC) treatme...
Autores principales: | Venkat, Poornima, Culmone, Lauren, Chopp, Michael, Landschoot-Ward, Julie, Wang, Fengjie, Zacharek, Alex, Chen, Jieli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461871/ https://www.ncbi.nlm.nih.gov/pubmed/32973489 http://dx.doi.org/10.3389/fnagi.2020.00258 |
Ejemplares similares
-
Treatment With an Angiopoietin-1 Mimetic Peptide Improves Cognitive Outcome in Rats With Vascular Dementia
por: Culmone, Lauren, et al.
Publicado: (2022) -
Early therapeutic effects of an Angiopoietin-1 mimetic peptide in middle-aged rats with vascular dementia
por: Gao, Huanjia, et al.
Publicado: (2023) -
Treatment with an Angiopoietin‐1 mimetic peptide promotes neurological recovery after stroke in diabetic rats
por: Venkat, Poornima, et al.
Publicado: (2020) -
Deficiency of Endothelial Nitric Oxide Synthase (eNOS) Exacerbates Brain Damage and Cognitive Deficit in A Mouse Model of Vascular Dementia
por: An, Lulu, et al.
Publicado: (2021) -
ApoA-I Mimetic Peptide Reduces Vascular and White Matter Damage After Stroke in Type-2 Diabetic Mice
por: Wang, Xiaohui, et al.
Publicado: (2019)